Research study of Bharat Biotech reflects that (BBV152) Covaxin counteracts best against Delta Plus (AY:1) variant of COVID-19.
The Indian Council of Medical and research’s findings showcased BBVi52 fights well against
Delta variants named as AY.1 and B.1.167.3. ICMR has so far detected AY.1, AY.2 and AY. 3 higher version variants
of Delta corona virus in Indian domain. Bharat Biotech’s study shows that
Covaxin vaccine is 65.2% effective against B.617.2 delta variant.
NEIC: SUMI BORA
No comments:
Post a Comment
Your highlight can be precious enough to make a change in the present system for better progress of the nation and so make a step to comment.